Armistice Capital LLC Decreases Stock Holdings in Agile Therapeutics, Inc.

AGRXDelisted Stock  USD 2.94  0.08  2.65%   
Slightly above 61% of Agile Thrpe's investor base is looking to short. The analysis of current outlook of investing in Agile Thrpe suggests that many traders are alarmed regarding Agile Thrpe's prospects. Agile Thrpe's investing sentiment can be driven by a variety of factors including economic data, Agile Thrpe's earnings reports, geopolitical events, and overall market trends.
  
Armistice Capital LLC reduced its stake in Agile Therapeutics, Inc. by 19.7 percent in the 3rd quarter, HoldingsChannel.com reports. The firm owned 98,000 shares of the specialty pharmaceutical companys stock after selling 24,000 shares during the period. Armistice Capital LLC owned about 0.05 percent of Agile Therapeutics worth 235,000 as of its most

Read at thelincolnianonline.com
news
  

Agile Thrpe Fundamental Analysis

We analyze Agile Thrpe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Agile Thrpe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Agile Thrpe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Agile Thrpe is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Agile Thrpe Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Agile Thrpe stock to make a market-neutral strategy. Peer analysis of Agile Thrpe could also be used in its relative valuation, which is a method of valuing Agile Thrpe by comparing valuation metrics with similar companies.

Peers

Agile Thrpe Related Equities

CPIXCumberland Pharmaceuticals   4.72   
0%
68.0%
AQSTAquestive Therapeutics   1.46   
0%
21.0%
SHPHShuttle Pharmaceuticals   1.16   
0%
16.0%
EVOKEvoke Pharma   0.92   
0%
13.0%
LFCRLifecore Biomedical   0.27   
3.0%
0%
AMRXAmneal Pharmaceuticals,   1.55   
22.0%
0%
TKNOAlpha Teknova   1.91   
27.0%
0%
ASRTAssertio Therapeutics   2.97   
43.0%
0%
PRFXPainreform   4.56   
66.0%
0%
CYTHCyclo Therapeutics   6.85   
99.0%
0%
PTPIPetros Pharmaceuticals   6.90   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Agile Stock

If you are still planning to invest in Agile Thrpe check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Agile Thrpe's history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators